Case Challenge

Selection of Initial Therapy for a 48-Year-Old HIV/TB-Coinfected Woman With Cardiovascular Disease Risk Factors

Source: Simple From the Start: The Importance of Treatment Convenience in Antiretroviral Therapy

Selection of Initial Therapy for a 48-Year-Old HIV/TB-Coinfected Woman With Cardiovascular Disease Risk Factors


Faculty:

  • Anton L. Pozniak, MD, FRCP

CME CREDIT INFORMATION

Release Date: 12/12/07

Expiration Date: 12/11/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the significance of simplified antiretroviral regimens in supporting patient adherence
  • Discuss factors to be considered when designing antiretroviral regimens for treatment-naive patients with comorbid conditions requiring concomitant treatment
  • Describe considerations in designing antiretroviral treatments to limit the risk of lipoatrophy
  • Identify appropriate strategies for the treatment of patients who are coinfected with HIV and tuberculosis

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.